Sort
78,016 grants matching “breast cancer”
Genomic Evolution of Breast Cancer
$683,942Arend Sidow · Stanford University · R01 · FY2016 · CA
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
$683,939Frederick R Appelbaum · University Of Washington · T32 · FY2008 · CA
Roles of BRCA2 in Mammalian Meiosis and Gamete Quality
$683,926Neil Hunter · University Of California At Davis · R01 · FY2025 · HD
Dynamics of Gene and Isoform Regulation during EMT and tumor progression
$683,847Frank B Gertler · Massachusetts Institute Of Technology · U01 · FY2016 · CA
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial
$683,810David M Williams · Brown University · R01 · FY2025 · CA
Probing cytosolic nucleic acid sensing pathways in cancer
$683,785Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$683,673John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA
The Epigenetic Enzyme CARM1 as a Negative Regulator of Dendritic cells and CD8 T cells in Melanoma
$683,670Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2025 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$683,560John Blenis · Harvard Medical School · R37 · FY2008 · CA
A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer
$683,542Jessica Scott · Sloan-Kettering Inst Can Research · R37 · FY2020 · CA
Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy
$683,497William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
$683,443Robert K Bradley · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$683,382Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Early Detection of Breast Cancer Using Autoantibody Mar*
$683,346Michael A Tainsky · Wayne State University · U01 · FY2007 · CA
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
$683,321Dawn Hershman · Columbia University Health Sciences · P50 · FY2022 · MD
PROTECTION AGAINST CHEMOTHERAPY ADVERSE EVENTS BY MACROMOLECULAR SUPEROXIDE DISMUTASE MIMETICS IN BREAST CANCER
$683,144Sanford Research · · FY2021 · Defense Health Agency
Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ
$683,130Swati Kulkarni · Northwestern University At Chicago · R01 · FY2020 · CA
Reproducible and Accurate PD-L1 Immunohistochemistry Biomarker Quantification Using Virtual Multiplex Immunofluorescence Restaining
$683,089Saad Nadeem · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
IMAGING NETWORK FOR BREAST CANCER MASS SCREENING
$683,053Armen Sarvazyan · Artann Laboratories, Inc. · R44 · FY2006 · CA
Multifactoral breast cancer risk prediction accounting for ethnic and tumor diversity
$683,035Peter Kraft · Harvard School Of Public Health · U01 · FY2020 · CA
EXAMINING THE ROLE OF CHROMOSOMAL INSTABILITY IN BREAST CANCER EVOLUTION
$683,023Sloan-Kettering Institute For Cancer Research · · FY2016 · Department of the Army
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
$682,890Louise C Showe · Wistar Institute · U01 · FY2016 · CA
Randomized Trial of a Mammography Decision Aid for Women Aged 75 and Older
$682,829Mara A Schonberg · Beth Israel Deaconess Medical Center · R01 · FY2015 · CA
Image-guided cancer therapy using heat activatable CAR T cells
$682,800Stanislav Y Emelianov · Georgia Institute Of Technology · R01 · FY2022 · EB
Radiomics and Pathomics to predict upstaging of DCIS
$682,707Bethany Lynn Niell · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA